Neonatal epidermolysis bullosa: a clinical practice guideline

Rebecca Saad1, José Duipmans2, Natalie Yerlett3

  • 1Sydney Children's Hospital Randwick, Sydney, NSW, Australia.

PubMed

Insights

This study outlines new clinical practice guidelines (CPGs) for neonatal epidermolysis bullosa (EB) care. These guidelines aim to standardize and improve the management of EB in newborns through evidence-based recommendations.

Area of Science:

  • Medical Research
  • Genodermatoses
  • Neonatal Care

Background:

  • Current neonatal care for epidermolysis bullosa (EB) relies on variable evidence, expertise, and trial-and-error.
  • There is a need for standardized, research-based knowledge to guide international practitioners in managing EB.
  • Early intervention and improved standards of care are crucial for individuals newly diagnosed with EB.

Purpose of the Study:

  • To develop comprehensive clinical practice guidelines (CPGs) for neonatal epidermolysis bullosa (EB) care.
  • To improve the clinical management and outcomes for neonates diagnosed with EB.
  • To establish a foundation of knowledge for international practitioners caring for EB patients.

Main Methods:

  • Development of CPGs by an international expert panel specializing in EB.
  • Systematic review methodology applied to four key areas of neonatal care.
  • Inclusion of a Hospital Implementation Tool to facilitate theory-to-practice transfer.

Main Results:

  • The CPG addresses critical areas: diagnosis, parental psychosocial support, hospital management (monitoring, wound care, pain), feeding, nutrition, and discharge planning.
  • Highlights the necessity of a multidisciplinary team approach for holistic, patient-specific care.
  • Emphasizes the integration of parental and carer needs and preferences into the care model.

Conclusions:

  • The developed CPG provides evidence-based recommendations for improving neonatal EB care.
  • A multidisciplinary, patient-specific approach is essential for optimal management of EB.
  • The guidelines and implementation tool aim to enhance the quality of life for individuals with EB and their families.

Related Concept Videos

Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K
Renewal of Skin Epidermal Stem Cells01:12

Renewal of Skin Epidermal Stem Cells

The skin is divided into epidermis, dermis, and hypodermis, the skin's outermost, middle, and inner layers. The human epidermal layer regularly undergoes renewal, where old, dead cells are replaced by new cells. Epidermal stem cells or EpiSCs divide and differentiate to restore the lost cells. For the renewal process, some EpiSCs continuously self-renew. In contrast, few others differentiate into transit-amplifying cells, which later form prickle or spinous cells, followed by granular...
2.5K
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.1K